These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 6295263)

  • 1. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
    Hooper DC; Wolfson JS; McHugh GL; Winters MB; Swartz MN
    Antimicrob Agents Chemother; 1982 Oct; 22(4):662-71. PubMed ID: 6295263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin.
    Tsai FT; Singh OM; Skarzynski T; Wonacott AJ; Weston S; Tucker A; Pauptit RA; Breeze AL; Poyser JP; O'Brien R; Ladbury JE; Wigley DB
    Proteins; 1997 May; 28(1):41-52. PubMed ID: 9144789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance genes of aminocoumarin producers: two type II topoisomerase genes confer resistance against coumermycin A1 and clorobiocin.
    Schmutz E; Mühlenweg A; Li SM; Heide L
    Antimicrob Agents Chemother; 2003 Mar; 47(3):869-77. PubMed ID: 12604514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial and DNA gyrase-inhibitory activities of novel clorobiocin derivatives produced by mutasynthesis.
    Galm U; Heller S; Shapiro S; Page M; Li SM; Heide L
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1307-12. PubMed ID: 15047534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Installation of the pyrrolyl-2-carboxyl pharmacophore by CouN1 and CouN7 in the late biosynthetic steps of the aminocoumarin antibiotics clorobiocin and coumermycin A1.
    Garneau-Tsodikova S; Stapon A; Kahne D; Walsh CT
    Biochemistry; 2006 Jul; 45(28):8568-78. PubMed ID: 16834331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of plasmid pMG110 from Escherichia coli by novobiocin and other inhibitors of DNA gyrase.
    Hooper DC; Wolfson JS; McHugh GL; Swartz MD; Tung C; Swartz MN
    Antimicrob Agents Chemother; 1984 May; 25(5):586-90. PubMed ID: 6329090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novenamine is the active moiety in novobiocin.
    Reusser F; Dolak LA
    J Antibiot (Tokyo); 1986 Feb; 39(2):272-4. PubMed ID: 3007416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of ribosomal ribonucleic acid synthesis by deoxyribonucleic acid gyrase activity in Escherichia coli.
    Oostra BA; van Vliet AJ; Ab G; Gruber M
    J Bacteriol; 1981 Dec; 148(3):782-7. PubMed ID: 6171557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin.
    Stieger M; Angehrn P; Wohlgensinger B; Gmünder H
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1060-2. PubMed ID: 8849232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA gyrase activities from Rhodobacter capsulatus: analysis of target(s) of coumarins and cloning of the gyrB locus.
    Kranz RG; Beckman DL; Foster-Hartnett D
    FEMS Microbiol Lett; 1992 May; 72(1):25-32. PubMed ID: 1319375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between coumarin drugs and DNA gyrase.
    Maxwell A
    Mol Microbiol; 1993 Aug; 9(4):681-6. PubMed ID: 8231802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.
    Gellert M; O'Dea MH; Itoh T; Tomizawa J
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4474-8. PubMed ID: 794878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of aminocoumarin-type gyrase and topoisomerase IV inhibitors obtained by combinatorial biosynthesis.
    Flatman RH; Eustaquio A; Li SM; Heide L; Maxwell A
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1136-42. PubMed ID: 16569821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of coumarincarboxylic acids as inhibitors of gyrase B. L-rhamnose as an effective substitute for L-noviose.
    Ferroud D; Collard J; Klich M; Dupuis-Hamelin C; Mauvais P; Lassaigne P; Bonnefoy A; Musicki B
    Bioorg Med Chem Lett; 1999 Oct; 9(19):2881-6. PubMed ID: 10522711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coumarin and quinolone action in archaebacteria: evidence for the presence of a DNA gyrase-like enzyme.
    Sioud M; Possot O; Elie C; Sibold L; Forterre P
    J Bacteriol; 1988 Feb; 170(2):946-53. PubMed ID: 2828337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins.
    Marcu MG; Schulte TW; Neckers L
    J Natl Cancer Inst; 2000 Feb; 92(3):242-8. PubMed ID: 10655441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of coumarin antibiotics with fragments of DNA gyrase B protein.
    Gormley NA; Orphanides G; Meyer A; Cullis PM; Maxwell A
    Biochemistry; 1996 Apr; 35(15):5083-92. PubMed ID: 8664301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coumermycin A1 inhibits growth and induces relaxation of supercoiled plasmids in Borrelia burgdorferi, the Lyme disease agent.
    Samuels DS; Garon CF
    Antimicrob Agents Chemother; 1993 Jan; 37(1):46-50. PubMed ID: 8381639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I.
    Tabary X; Moreau N; Dureuil C; Le Goffic F
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1925-8. PubMed ID: 2830840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations affecting gyrase in Haemophilus influenzae.
    Setlow JK; Cabrera-Juárez E; Albritton WL; Spikes D; Mutschler A
    J Bacteriol; 1985 Nov; 164(2):525-34. PubMed ID: 2997115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.